Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting the Risk of Readmission in Patients With Chronic Heart Failure

NCT04984928 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04984928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04984928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting the Risk of Readmission in Patients With Chronic Heart Failure
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
September 20, 2021
Completion date
December 30, 2022
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure